Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy

Journal of the American College of Cardiology

Volumn 60, Issue 10, 2012, Pages 922-929

  Todiere, Giancarlo ^a   Aquaro, Giovanni Donato ^a   Piaggi, Paolo ^b   Formisano, Francesco ^c   Barison, Andrea ^d   Masci, Pier Giorgio ^a   Strata, Elisabetta ^a   Bacigalupo, Lorenzo ^c   Marzilli, Mario ^b   Pingitore, Alessandro ^e   Lombardi, Massimo ^a  

^a FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c GALLIERA HOSPITAL   (Italy)

^d SCUOLA SUPERIORE SANT ANNA   (Italy)

^e INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

cardiac magnetic resonance; hypertrophic cardiomyopathy; late gadolinium enhancement; myocardial fibrosis

Indexed keywords

GADOLINIUM PENTETATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; COMPUTED TOMOGRAPHY SCANNER; CONTRAST ENHANCEMENT; DISEASE COURSE; FEMALE; FUNCTIONAL STATUS; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE FUNCTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; DISEASE PROGRESSION; FEMALE; FIBROSIS; GADOLINIUM; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MYOCARDIUM; PROGNOSIS; RADIOPHARMACEUTICALS; SAMPLE SIZE; TIME FACTORS; VENTRICULAR DYSFUNCTION;

EID: 84865498608     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.03.076     Document Type: Article

References (29)

1. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320
2. P.M. Elliott, J. Poloniecki, S. Dickie Sudden death in hypertrophic cardiomyopathy: identification of high risk patients J Am Coll Cardiol 36 2000 2212 2218
3. E. Biagini, F. Coccolo, M. Ferlito Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients J Am Coll Cardiol 46 2005 1543 1550
4. J. Diez Mechanisms of cardiac fibrosis in hypertension J Clin Hypertens (Greenwich) 9 2007 546 550
5. B.J. Maron, P. Spirito Implications of left ventricular remodeling in hypertrophic cardiomyopathy Am J Cardiol 81 1998 1339 1344
6. D.S. Choi, J.W. Ha, B. Choi Extent of late gadolinium enhancement in cardiovascular magnetic resonance and its relation with left ventricular diastolic function in patients with hypertrophic cardiomyopathy Circ J 72 2008 1449 1453
7. A.M. Varnava, P.M. Elliott, N. Mahon, M.J. Davies, W.J. McKenna Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy Am J Cardiol 88 2001 275 279
8. J.C. Moon, E. Reed, M.N. Sheppard The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 43 2004 2260 2264
9. R. O'Hanlon, A. Grasso, M. Roughton Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 867 874
10. O. Bruder, A. Wagner, C.J. Jensen Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 875 887
11. L.G. Shewan, A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2
12. B.J. Maron, W.J. McKenna, G.K. Danielson American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713
13. J.J. Goldberger, M.E. Cain, S.H. Hohnloser American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention J Am Coll Cardiol 52 2008 1179 1199
14. U. Sechtem, P. Pflugfelder, C.B. Higgins Quantification of cardiac function by conventional and cine magnetic resonance imaging Cardiovasc Intervent Radiol 10 1987 365 373
15. A.M. Maceira, S.K. Prasad, M. Khan, D.J. Pennell Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance J Cardiovasc Magn Reson 8 2006 417 426
16. C. Rickers, N.M. Wilke, M. Jerosch-Herold Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy Circulation 112 2005 855 861
17. G.D. Aquaro, V. Positano, A. Pingitore Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy J Cardiovasc Magn Reson 12 2010 21
18. C.J. Harrigan, D.C. Peters, C.M. Gibson Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging Radiology 258 2011 128 133
19. A.S. Adabag, B.J. Maron, E. Appelbaum Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance J Am Coll Cardiol 51 2008 1369 1374
20. R. Gebker, M. Neuss, I. Paetsch, E. Nagel Images in cardiovascular medicine Progressive myocardial fibrosis in a patient with apical hypertrophic cardiomyopathy detected by cardiovascular magnetic resonance Circulation 114 2006 e75 e76
21. J. Moon, I.J. Cho, C.Y. Shim Abnormal myocardial capillary density in apical hypertrophic cardiomyopathy can be assessed by myocardial contrast echocardiography Circ J 74 2010 2166 2172
22. T. Kubo, H. Kitaoka, M. Okawa Clinical profiles of hypertrophic cardiomyopathy with apical phenotypecomparison of pure-apical form and distal-dominant form Circ J 73 2009 2330 2336
23. K. Matsubara, T. Nakamura, T. Kuribayashi, A. Azuma, M. Nakagawa Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy J Am Coll Cardiol 42 2003 288 295
24. M.S. Maron, J.J. Finley, J.M. Bos Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy Circulation 118 2008 1541 1549
25. M.J. Eriksson, B. Sonnenberg, A. Woo Long-term outcome in patients with apical hypertrophic cardiomyopathy J Am Coll Cardiol 39 2002 638 645
26. G.D. Aquaro, P. Masci, F. Formisano Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity Am J Cardiol 105 2010 392 397
27. M.S. Maron, E. Appelbaum, C.J. Harrigan Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy Circ Heart Fail 1 2008 184 191
28. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
29. C.J. Soriano, F. Ridocci, J. Estornell, J. Jimenez, V. Martinez, J.A. De Velasco Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance J Am Coll Cardiol 45 2005 743 748